William Denby, Director at DMK Pharmaceuticals, holds 108.75K shares in DMK Pharmaceuticals (Ticker: DMKPQ), holds 0.00 shares in Santarus (Ticker: SNTS). Most recently, William Denby Bought ― shares of DMK Pharmaceuticals on May 28, 2019 for an estimated value of 9.94K.